MedPath

The Effect of Cool Dialysate on Depressio

Not Applicable
Conditions
Chronic kidney disease, Under Hemodialysis.
Chronic kidney disease, stage 5
N18.5
Registration Number
IRCT20200215046495N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
66
Inclusion Criteria

Having informed consent to participate in the study
Ages over 18 years of any gender
Patient with a diagnosis of chronic renal failure (patients who have been hemodialysis for 6 months)
Under hemodialysis 3 times a week and each session 4 hours
Have complete alertness and acceptable verbal and hearing ability to answer questions
Patients with KT/V greater than or equal to 1

Exclusion Criteria

Treated with antidepressants
Malignancy
Known hypothyroidism
Patients with hemoglobin less than 8 mg/dL
Patients whose access to the vessels is through a temporary catheter or Shaldon

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score on Beck Questionnaire 2. Timepoint: Measurement of depression score before and after the last intervention session (end of the 12th hemodialysis session) and two weeks after the intervention. Method of measurement: Beck Depression Inventory II (BDI-II).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath